Maravai LifeSciences Holdings, Inc. (MRVI) Financials

MRVI Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 603.7 million 248.2 million
March 31, 2026 713.2 million 344.1 million
Dec. 31, 2025 770.6 million 397.9 million
Sept. 30, 2025 849.2 million 417.3 million

MRVI Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 3.6 million 16.9 million
March 31, 2026 4.2 million 6.7 million
Dec. 31, 2025 -24.9 million 3.9 million
Sept. 30, 2025 -18.1 million 9.1 million

MRVI Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 -12.4 million
March 31, 2026 -3.7 million
Dec. 31, 2025 -40.1 million
Sept. 30, 2025 -25.6 million

MRVI Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 70.1 million 146.0 million 29.6 million
March 31, 2026 165.9 million 235.6 million 29.9 million
Dec. 31, 2025 216.9 million 30.1 million 72.9 million
Sept. 30, 2025 243.6 million 30.4 million 75.1 million

MRVI Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 148.0 million
March 31, 2026 146.4 million
Dec. 31, 2025 145.1 million
Sept. 30, 2025 144.7 million

MRVI Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 370000 3.7 million 32.1 million -
March 31, 2026 4.4 million 3.9 million 27.3 million -
Dec. 31, 2025 2.1 million 3.8 million 15.2 million -
Sept. 30, 2025 2.9 million 9.8 million 78.1 million -

MRVI Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 51.4 million 30.8 million
March 31, 2026 65.8 million 32.1 million
Dec. 31, 2025 49.9 million 37.6 million
Sept. 30, 2025 41.6 million 36.0 million

MRVI Revenue by Segment
Graph available only for paid members. Upgrade to see it.

MRVI

Price: $7.07

52 week price:
2.55
9.42

Earnings Per Share: -0.53 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 1.1 million

Market Capitalization: 2.1 billion

Links: